BridgeBio Pharma, Inc.(BBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBIO BridgeBio Pharma, Inc.

已收盘 07-26 16:00:00 EDT

27.05

+0.35

+1.31%

盘后27.05

+0.000.00%

17:19 EDT

最高27.84	最低26.61	成交量88.59万
今开27.40	昨收26.70	日振幅4.61%
总市值50.62亿	流通市值32.79亿	总股本1.87亿
成交额2,403万	换手率0.73%	流通股本1.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBIO","market":"US","secType":"STK","nameCN":"BridgeBio Pharma, Inc.","latestPrice":27.05,"timestamp":1722024000000,"preClose":26.7,"halted":0,"volume":885913,"hourTrading":{"tag":"盘后","latestPrice":27.05,"preClose":27.05,"latestTime":"17:19 EDT","volume":34229,"amount":925893.92,"timestamp":1722028755517},"delay":0,"floatShares":121209609,"shares":187129260,"eps":-3.179217,"marketStatus":"已收盘","marketStatusCode":5,"change":0.35,"latestTime":"07-26 16:00:00 EDT","open":27.4,"high":27.84,"low":26.61,"amount":24033077.099129,"amplitude":0.046067,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.179217,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1561608000000,"adjPreClose":26.7,"preHourTrading":{"tag":"盘前","latestPrice":27.4,"preClose":26.7,"latestTime":"09:29 EDT","volume":839,"amount":22911.079756000003,"timestamp":1722000599999},"postHourTrading":{"tag":"盘后","latestPrice":27.05,"preClose":27.05,"latestTime":"17:19 EDT","volume":34229,"amount":925893.92,"timestamp":1722028755517},"volumeRatio":0.803446,"impliedVol":0.6026,"impliedVolPercentile":0.1746},"requestUrl":"/m/hq/s/BBIO","defaultTab":"news","newsList":[{"id":"2452148079","title":"Bridgebio Pharma, Inc.盘中异动 早盘股价大跌5.11%报26.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452148079","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452148079?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:35","pubTimestamp":1721313303,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时35分，Bridgebio Pharma, Inc.股票出现异动，股价快速下跌5.11%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Onconetix, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs较为活跃，换手率分别为1774.81%、999.66%、142.99%，振幅较大的相关个股有Silo Pharma, Inc.、Onconetix, Inc.、Nkgen Biotech, Inc.，振幅分别为93.33%、86.24%、37.39%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718223503941f85a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718223503941f85a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","BK4505","BBIO"],"gpt_icon":0},{"id":"2452161345","title":"Bridgebio Pharma, Inc.盘中异动 大幅跳水5.13%报27.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452161345","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452161345?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:42","pubTimestamp":1721230939,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时42分，Bridgebio Pharma, Inc.股票出现波动，股价大幅下跌5.13%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体跌幅为2.06%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3064.99%、1331.73%、281.26%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为76.39%、46.25%、43.75%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172342209681db52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172342209681db52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4505","BK4585","BBIO"],"gpt_icon":0},{"id":"2452794788","title":"Bridgebio Pharma, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452794788","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452794788?lang=zh_cn&edition=full","pubTime":"2024-07-17 03:53","pubTimestamp":1721159612,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日03时53分，Bridgebio Pharma, Inc.股票出现波动，股价急速拉升5.03%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Silo Pharma, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为4573.11%、1357.55%、436.72%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Silo Pharma, Inc.、Scisparc Ltd.，振幅分别为79.41%、75.69%、72.88%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170353339681d468&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170353339681d468&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4585","BK4588","BBIO"],"gpt_icon":0},{"id":"2446563258","title":"Bridgebio Pharma, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446563258","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446563258?lang=zh_cn&edition=full","pubTime":"2024-06-28 00:47","pubTimestamp":1719506850,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日00时47分，Bridgebio Pharma, Inc.股票出现异动，股价大幅拉升5.01%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Onconetix, Inc.涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2651.11%、367.17%、338.63%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为322.04%、127.05%、81.43%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628004730968178c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628004730968178c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","BK4505","BBIO"],"gpt_icon":0},{"id":"2446007110","title":"BUZZ-Alnylam 因心脏病药物在关键研究中获得成功而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2446007110","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446007110?lang=zh_cn&edition=full","pubTime":"2024-06-25 01:42","pubTimestamp":1719250931,"startTime":"0","endTime":"0","summary":" (更新)    6月24日 - ** Alnylam Pharmaceuticals  股价大涨40%至231.64美元，创下自2023年2月以来的最高水平 。** 如果涨势保持，市值将增加80多亿美元** 该公司称其心脏病药物vutrisiran在一项受到密切关注的后期研究中达到了  主要目标和所有次要目标** 该药物vutrisiran有助于将一种被称为ATTR-CM的罕见心脏病患者的死亡人数和心脏相关住院治疗人数减少33%。** ALNY 公司的药物通过关闭转甲状腺素蛋白的不规则生产而发挥作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4588","BK4585","BK4556","BK4548","BUZZ","NTLA","BK4505","LU1861558580.USD","BK4139","IONS","BK4535","LU1861559042.SGD","ALNY"],"gpt_icon":0},{"id":"2445749330","title":"Bridgebio Pharma, Inc.盘中异动 大幅下跌11.15%报24.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445749330","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445749330?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235903,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分，Bridgebio Pharma, Inc.股票出现异动，股价快速跳水11.15%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。消息层面，截至21时31分，《TD Cowen维持BridgeBio Pharma买入评级》资讯为影响Bridgebio Pharma, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242131439f600055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242131439f600055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBIO","BK4585","BK4588","BK4139","BK4505"],"gpt_icon":0},{"id":"2443676921","title":"Bridgebio Pharma, Inc.盘中异动 股价大跌5.00%报27.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443676921","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443676921?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:17","pubTimestamp":1718374636,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时17分，Bridgebio Pharma, Inc.股票出现异动，股价急速跳水5.00%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Cns Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Longeveron Inc.、Bio-Path Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为712.57%、201.55%、164.44%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Kyverna Therapeutics, Inc.，振幅分别为88.40%、57.51%、39.40%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614221716af8da34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614221716af8da34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4505","BBIO","BK4139"],"gpt_icon":0},{"id":"2442554211","title":"Bridgebio Pharma, Inc.盘中异动 早盘急速拉升5.06%报28.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442554211","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442554211?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:30","pubTimestamp":1718199059,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时30分，Bridgebio Pharma, Inc.股票出现波动，股价大幅上涨5.06%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Avidity Biosciences, Inc.、Molecular Partners Ag、Passage Bio, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为35.58%、18.76%、3.50%，振幅较大的相关个股有Xortx Therapeutics Inc.、Passage Bio, Inc.、Curevac N.V.，振幅分别为20.93%、18.35%、7.06%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213059941ee092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213059941ee092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BBIO","BK4585","BK4588","BK4505"],"gpt_icon":0},{"id":"2440351452","title":"Bridgebio Pharma, Inc.盘中异动 股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440351452","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440351452?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:31","pubTimestamp":1717507918,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时31分，Bridgebio Pharma, Inc.股票出现异动，股价大幅上涨6.14%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Equillium, Inc.较为活跃，换手率分别为35.50%、34.70%、20.10%，振幅较大的相关个股有Fresh2 Group Limited、康乃德生物、Equillium, Inc.，振幅分别为14.90%、14.03%、12.92%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406042131589f191681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406042131589f191681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4585","BBIO","BK4588"],"gpt_icon":0},{"id":"2440238766","title":"BUZZ-BridgeBio公司在遗传病治疗中期试验中取得积极进展，业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2440238766","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440238766?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:13","pubTimestamp":1717506790,"startTime":"0","endTime":"0","summary":"    6月4日 - ** 药物开发商BridgeBio Pharma   股价盘前上涨8%至31.29美元** 该公司称，其口服疗法 infigratinib 在一项中期试验中显示， ，软骨发育不全患者的身体比例有了显著改善。** 软骨发育症是一种遗传性骨骼生长障碍，会导致短肢侏儒症** BMO Capital Markets分析师认为，这些数据表明，infigratinib的后期试验数据很可能与BioMarin Pharmaceutical公司的  软骨发育不全药物Voxzogo相当或更胜一筹。** 截至上日收盘，股价累计下跌28.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B19Z3B42.SGD","BK4585","BK4505","IE00B7SZLL34.SGD","BK4588","BMRN","IE00B19Z3581.USD","IE0002270589.USD","BBIO","BUZZ","BK4566"],"gpt_icon":0},{"id":"2438308243","title":"坎托菲茨杰拉德公司：重申BridgeBio Pharma(BBIO.US)评级，由增持调整至增持评级, 目标价由70.00美元调整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2438308243","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438308243?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:15","pubTimestamp":1716905759,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申BridgeBio Pharma(BBIO.US)评级，由增持调整至增持评级, 目标价由70.00美元调整至70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282216039ef9d093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282216039ef9d093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBIO"],"gpt_icon":0},{"id":"2438377085","title":"BridgeBio Pharma Inc：瑞银将目标价格从51美元下调至47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438377085","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438377085?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:26","pubTimestamp":1716902812,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc：瑞银将目标价格从51美元下调至47美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282126559ef99743&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282126559ef99743&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBIO"],"gpt_icon":0},{"id":"2435568188","title":"美国研究综述-Akoya Biosciences、波士顿啤酒公司、胜利资本控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2435568188","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435568188?lang=zh_cn&edition=full","pubTime":"2024-05-14 15:22","pubTimestamp":1715671336,"startTime":"0","endTime":"0","summary":"    路透5月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Akoya Biosciences、波士顿啤酒公司和 Victory Capital Holdings。要点              * Akoya Biosciences Inc   ：Canaccord Genuity将目标价从10美元下调至6美元              * 波士顿啤酒公司   ：杰富瑞将目标价从335美元上调至360美元             * Fortrea Holdings Inc   ：Evercore ISI将目标价从43美元下调至31美元              * Medical Properties Trust Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHF","BK4121","BK4096","FTRE","SG9999003800.SGD","CTRE","MPW","BK4120","IOVA","BBIO","MSGE","CIVB","LOB","SG9999011175.SGD","CHUY","FIVE","FULC","BK4551","GPRE","BK4007","BK4566","NBIX","STZ","BK4583","EMR","APDN","LEGN","NGNE","BK4203","ACLX","NOTV","JELD","MRNA","VCTR","NNI","OBDC","DH","AGL","SAM","CDNA","CMPX","ARIS","BK4135","JXN","LU2249611893.SGD","AKYA","NHI","ATLC","BK4568","BMRN"],"gpt_icon":0},{"id":"2432907126","title":"BridgeBio Pharma Inc 公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432907126","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432907126?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:43","pubTimestamp":1714751006,"startTime":"0","endTime":"0","summary":"   * BridgeBio Pharma Inc   报告了截至3月底的季度调整后每股亏损20美分，高于去年同期的每股-92美分。华尔街预期为每股亏损 1.08 美元至-74 美分。* 营收同比增长 11461.9%，达到 2.1112 亿美元；分析师预期为 1403 万美元。* BridgeBio Pharma 公司公布的本季度每股收益为亏损 20 美分。* 该公司当季亏损 3522 万美元。* BridgeBio Pharma Inc 本季度股价下跌了 10.3%，今年迄今为止下跌了 31.3%。5月3日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 6.2%。华尔街对 BridgeBio Pharma Inc 的 12 个月目标价中位数为 50.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BBIO","BK4505","BK4139"],"gpt_icon":0},{"id":"2432153377","title":"BridgeBio Pharma Inc   预计每股亏损89美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432153377","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432153377?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:25","pubTimestamp":1714494308,"startTime":"0","endTime":"0","summary":"   * BridgeBio Pharma Inc    预计将在5月2日公布截至2024年3月31日的季度业绩(预计)，季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于加利福尼亚州帕洛阿尔托的公司的营收预计将从去年同期的183万美元增长668.5%，达到1403.4万美元。* LSEG 分析师对 BridgeBio Pharma Inc 的平均预期是每股亏损 89 美分。* 华尔街对 BridgeBio Pharma Inc 的 12 个月目标价中值为 50.00 美元，高于其上次收盘价 25.47 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO"],"gpt_icon":0},{"id":"2426734287","title":"Bridgebio Pharma, Inc.盘中异动 临近午盘快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426734287","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426734287?lang=zh_cn&edition=full","pubTime":"2024-04-12 23:43","pubTimestamp":1712936581,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日23时43分，Bridgebio Pharma, Inc.股票出现波动，股价快速跳水5.01%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Allarity Therapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3399.94%、1343.08%、82.63%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为90.30%、60.95%、58.59%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041223430279203ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041223430279203ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBIO","BK4505","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2426299354","title":"Bridgebio Pharma, Inc.盘中异动 下午盘急速上涨5.01%报28.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426299354","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426299354?lang=zh_cn&edition=full","pubTime":"2024-04-12 02:17","pubTimestamp":1712859445,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日02时17分，Bridgebio Pharma, Inc.股票出现异动，股价快速拉升5.01%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Candel Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为812.12%、614.74%、516.20%，振幅较大的相关个股有Veru Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Rallybio Corporation，振幅分别为53.23%、52.42%、50.92%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041202172587e7faef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041202172587e7faef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4585","BK4588","BBIO"],"gpt_icon":0},{"id":"2426487254","title":"Bridgebio Pharma, Inc.盘中异动 下午盘大幅下跌5.08%报26.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426487254","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426487254?lang=zh_cn&edition=full","pubTime":"2024-04-11 01:07","pubTimestamp":1712768847,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日01时07分，Bridgebio Pharma, Inc.股票出现波动，股价急速跳水5.08%。Bridgebio Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Clene Inc C/Wts 30/12/2025 涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1946.31%、76.78%、53.12%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Orgenesis Inc.、Nutriband Inc C/Wts ，振幅分别为87.61%、74.23%、52.44%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110107287a51ed76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110107287a51ed76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBIO","BK4505","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2421045058","title":"Bridgebio Pharma, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421045058","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421045058?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:45","pubTimestamp":1711028743,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时45分，Bridgebio Pharma, Inc.股票出现异动，股价快速拉升5.03%。Bridgebio Pharma, Inc.公司简介：BridgeBio Pharma Inc 参与确定用于治疗孟德尔病患者的先进变革性药物，以及具有明确基因驱动因素的癌症。消息层面，截至21时45分，Bridgebio Pharma, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214543791c0695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214543791c0695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BBIO","BK4505"],"gpt_icon":0},{"id":"2420798966","title":"美国研究综述-迪克体育用品、Nvidia、PVH","url":"https://stock-news.laohu8.com/highlight/detail?id=2420798966","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420798966?lang=zh_cn&edition=full","pubTime":"2024-03-20 15:14","pubTimestamp":1710918896,"startTime":"0","endTime":"0","summary":"    路透社3月20日 - 华尔街证券分析师周三调整了对迪克体育用品公司、英伟达和 PVH 等几家美国上市公司的评级和目标价。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4527","LU0238689110.USD","LU0444971666.USD","LU0170899867.USD","IE00BMPRXN33.USD","LU0731783394.SGD","PLNT","SAIC","NVDA","SMPL","CRNX","BK4503","BRO","RLMD","BK4212","TRML","CSCO","BK4213","DKS","SG9999002224.SGD","HQY","PTCT","CNM","BK4139","BK4505","BBIO","BK4023","CAL","HPP","MTDR","LU0889565916.HKD","LU0072462426.USD","SNDX","PVH","RIOT","BK4216","HLT","LU1430594728.SGD","SG9999002232.USD","RAIL","BK4525","GOCO","LU0053671581.USD","BK4543","IE00BWXC8680.SGD","ASO","BK4588","DCPH","RCM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bridgebio.com","stockEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.142},{"period":"3month","weight":0.0732},{"period":"6month","weight":-0.2571},{"period":"1year","weight":-0.1762},{"period":"ytd","weight":-0.3386}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BridgeBio Pharma, Inc.于2019年5月17日成立为特拉华州公司。他们是一个由经验丰富的药物发现者，开发者和创新者组成的团队，致力于创造改变生命的药物，从源头上瞄准特征明确的遗传性疾病。他们确定和推进转化药物治疗患有孟德尔疾病的患者，这些疾病是由单一基因缺陷引起的疾病，以及具有明确遗传驱动因素的癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.111762},{"month":2,"riseRate":0.4,"avgChangeRate":0.037273},{"month":3,"riseRate":0.4,"avgChangeRate":0.087947},{"month":4,"riseRate":0.2,"avgChangeRate":-0.108991},{"month":5,"riseRate":0.4,"avgChangeRate":-0.018168},{"month":6,"riseRate":0.8,"avgChangeRate":0.125791},{"month":7,"riseRate":0.5,"avgChangeRate":0.145212},{"month":8,"riseRate":0.6,"avgChangeRate":0.020787},{"month":9,"riseRate":0.2,"avgChangeRate":-0.055084},{"month":10,"riseRate":0.8,"avgChangeRate":0.03327},{"month":11,"riseRate":0.6,"avgChangeRate":0.082541},{"month":12,"riseRate":0.6,"avgChangeRate":0.051049}],"exchange":"NASDAQ","name":"BridgeBio Pharma, Inc.","nameEN":"BridgeBio Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BridgeBio Pharma, Inc.(BBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BridgeBio Pharma, Inc.(BBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BridgeBio Pharma, Inc.,BBIO,BridgeBio Pharma, Inc.股票,BridgeBio Pharma, Inc.股票老虎,BridgeBio Pharma, Inc.股票老虎国际,BridgeBio Pharma, Inc.行情,BridgeBio Pharma, Inc.股票行情,BridgeBio Pharma, Inc.股价,BridgeBio Pharma, Inc.股市,BridgeBio Pharma, Inc.股票价格,BridgeBio Pharma, Inc.股票交易,BridgeBio Pharma, Inc.股票购买,BridgeBio Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BridgeBio Pharma, Inc.(BBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BridgeBio Pharma, Inc.(BBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}